Zetterberg H - Search Results

1

Exercise as a potential modulator of inflammation in patients with Alzheimer's disease measured in cerebrospinal fluid and plasma.

Jensen CS, Bahl JM, Østergaard LB, Høgh P, Wermuth L, Heslegrave A, Zetterberg H, Heegaard NHH, Hasselbalch SG, Simonsen AH. Jensen CS, et al. Among authors: zetterberg h. Exp Gerontol. 2019 Jul 1;121:91-98. doi: 10.1016/j.exger.2019.04.003. Epub 2019 Apr 11. Exp Gerontol. 2019. PMID: 30980923 Free article. Clinical Trial.

2

Cerebrospinal fluid markers for prediction of Alzheimer's disease.

Zetterberg H, Wahlund LO, Blennow K. Zetterberg H, et al. Neurosci Lett. 2003 Nov 27;352(1):67-9. doi: 10.1016/j.neulet.2003.08.011. Neurosci Lett. 2003. PMID: 14615052

3

Increased cerebrospinal fluid levels of transforming growth factor-beta1 in Alzheimer's disease.

Zetterberg H, Andreasen N, Blennow K. Zetterberg H, et al. Neurosci Lett. 2004 Sep 2;367(2):194-6. doi: 10.1016/j.neulet.2004.06.001. Neurosci Lett. 2004. PMID: 15331151

4

Genetic association of CDC2 with cerebrospinal fluid tau in Alzheimer's disease.

Johansson A, Zetterberg H, Hampel H, Buerger K, Prince JA, Minthon L, Wahlund LO, Blennow K. Johansson A, et al. Among authors: zetterberg h. Dement Geriatr Cogn Disord. 2005;20(6):367-74. doi: 10.1159/000088634. Epub 2005 Sep 29. Dement Geriatr Cogn Disord. 2005. PMID: 16192727

5

Cystatin C in cerebrospinal fluid and multiple sclerosis.

Hansson SF, Simonsen AH, Zetterberg H, Andersen O, Haghighi S, Fagerberg I, Andréasson U, Westman-Brinkmalm A, Wallin A, Rüetschi U, Blennow K. Hansson SF, et al. Among authors: zetterberg h. Ann Neurol. 2007 Aug;62(2):193-6; discussion 205. doi: 10.1002/ana.20945. Ann Neurol. 2007. PMID: 16900522

6

An Alzheimer's disease-specific beta-amyloid fragment signature in cerebrospinal fluid.

Portelius E, Zetterberg H, Andreasson U, Brinkmalm G, Andreasen N, Wallin A, Westman-Brinkmalm A, Blennow K. Portelius E, et al. Among authors: zetterberg h. Neurosci Lett. 2006 Dec 6;409(3):215-9. doi: 10.1016/j.neulet.2006.09.044. Epub 2006 Oct 17. Neurosci Lett. 2006. PMID: 17049739

7

Novel panel of cerebrospinal fluid biomarkers for the prediction of progression to Alzheimer dementia in patients with mild cognitive impairment.

Simonsen AH, McGuire J, Hansson O, Zetterberg H, Podust VN, Davies HA, Waldemar G, Minthon L, Blennow K. Simonsen AH, et al. Among authors: zetterberg h. Arch Neurol. 2007 Mar;64(3):366-70. doi: 10.1001/archneur.64.3.366. Arch Neurol. 2007. PMID: 17353378

8

Intra-individual stability of CSF biomarkers for Alzheimer's disease over two years.

Zetterberg H, Pedersen M, Lind K, Svensson M, Rolstad S, Eckerström C, Syversen S, Mattsson UB, Ysander C, Mattsson N, Nordlund A, Vanderstichele H, Vanmechelen E, Jonsson M, Edman A, Blennow K, Wallin A. Zetterberg H, et al. J Alzheimers Dis. 2007 Nov;12(3):255-60. doi: 10.3233/jad-2007-12307. J Alzheimers Dis. 2007. PMID: 18057559

9

Is plasma amyloid-beta a reliable biomarker for Alzheimer's disease?

Zetterberg H. Zetterberg H. Recent Pat CNS Drug Discov. 2008 Jun;3(2):109-11. doi: 10.2174/157488908784534595. Recent Pat CNS Drug Discov. 2008. PMID: 18537770 Review.

10

Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease.

Zetterberg H, Andreasson U, Hansson O, Wu G, Sankaranarayanan S, Andersson ME, Buchhave P, Londos E, Umek RM, Minthon L, Simon AJ, Blennow K. Zetterberg H, et al. Arch Neurol. 2008 Aug;65(8):1102-7. doi: 10.1001/archneur.65.8.1102. Arch Neurol. 2008. PMID: 18695061

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,209 results

Search Page